What is Crohn's & Colitis Foundation?
Established in 1967 by a coalition of visionary founders including Irwin M. and Suzanne Rosenthal, William D. and Shelby Modell, and Henry D. Janowitz, M.D., the Crohn's & Colitis Foundation operates as a premier non-profit entity. The organization serves as a cornerstone for research, education, and support services for individuals navigating the challenges of Crohn's disease and ulcerative colitis. Through a volunteer-fueled model, the foundation bridges the gap between clinical research and patient care, maintaining a high-authority position in the healthcare sector by prioritizing the development of curative therapies and the enhancement of patient quality of life.
How much funding has Crohn's & Colitis Foundation raised?
Crohn's & Colitis Foundation has raised a total of $7M across 2 funding rounds:
Debt
$5M
Debt
$2M
Debt (2020): $5M with participation from PPP
Debt (2021): $2M led by PPP
Key Investors in Crohn's & Colitis Foundation
PPP
Public-Private Partnership
What's next for Crohn's & Colitis Foundation?
With the recent capital deployment, the foundation is poised to scale its research infrastructure and expand its reach within the global medical community. The strategic allocation of these funds will likely focus on advancing clinical trials, fostering collaborative partnerships with biotech innovators, and enhancing digital support platforms for patients. As the organization moves into its next phase of growth, the focus remains on leveraging this financial stability to drive long-term systemic improvements in the treatment and management of chronic digestive conditions, ensuring that the foundation remains at the forefront of medical innovation.
See full Crohn's & Colitis Foundation company page
